Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Sponsor: Tune Therapeutics, Inc.
Summary
This study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Tune-401 in adult participants with Chronic Hepatitis B.
Official title: Phase 1b Multicenter, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tune-401 in Participants With Chronic Hepatitis B Infection
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2024-11-29
Completion Date
2028-10-30
Last Updated
2026-01-06
Healthy Volunteers
No
Interventions
Tune-401
Epigenetic gene silencing therapy
Locations (3)
Queen Mary Hospital, University of Hong Kong
Hong Kong, Hong Kong
PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit
Chisinau, Moldova
New Zealand Clinical Research
Auckland, New Zealand